PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid

Drug Delivery

Volumn 20, Issue 7, 2013, Pages 277-284

  Lin, Tongyuan ^a   Fang, Qingying ^a   Peng, Daiyin ^a   Huang, Xia ^a   Zhu, Tingting ^a   Luo, Qing ^a   Zhou, Kai ^a   Chen, Weidong ^a  

^a ANHUI UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Encapsulation; Gambogenic acid; PEG15 SA; PEGylated non ionic surfactant vesicles; Release

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; CHOLESTEROL; DICETYL PHOSPHATE; GAMBOGENIC ACID; MACROGOL; NIOSOME; PEG15 SA; POLYSORBATE 20; POLYSORBATE 40; POLYSORBATE 60; SORBITAN LAURATE; SORBITAN PALMITATE; SORBITAN STEARATE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BILAYER MEMBRANE; CHEMICAL STRUCTURE; CIRCULATION TIME; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; ENCAPSULATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDRATION; HYDROGEN BOND; HYDROPHOBICITY; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RAT; RETICULOENDOTHELIAL SYSTEM; SINGLE DRUG DOSE; TEMPERATURE; THERAPY EFFECT; TRANSMISSION ELECTRON MICROSCOPY; ZETA POTENTIAL;

ANIMALS; BIOLOGICAL AVAILABILITY; CHOLESTEROL; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG STABILITY; FEMALE; HEXOSES; LIPOSOMES; MALE; MEDICINE, CHINESE TRADITIONAL; MONONUCLEAR PHAGOCYTE SYSTEM; ORGANOPHOSPHATES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; RATS; SOLUBILITY; SURFACE-ACTIVE AGENTS; TERPENES; XANTHONES;

EID: 84884582037     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717544.2013.836618     Document Type: Article

References (27)

1. Abdelbary G, El-gendy N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech 9:740-5.
2. Abd-Elbaty A, El-laithy HM, Tadros MI. (2008). Sucrosestearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium. Int J Pharmaceutics 357:189-98.
3. Aburahma MH, Abdelbary GA. (2012). Novel diphenyl dimethyl bicarboxylate provesicular powerders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation. Int J Pharmaceutics 422:139-50.
4. Aggarwal D, Kaur IP. (2005). Improved pharmacodynamics of timolol maleate from a mucoadhesive niosomal ophthalmic drug delivery system. Int J Pharmaceutics 290:155-9.
5. Biswas S, Dodwadkar NS, Deshpande PP, Torchilin VP. (2012). Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium- PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 10:1-8.
6. Cortesi R, Ravani L, Rinaldi F, et al. (2013). Intranasal immunization in mice with non-ionic surfactants vesicles containing HSV immunogens: a preliminary study as possible vaccine against genital herpes. Int J Pharmaceutics 440:229-37.
7. Cosco D, Paolino D, Muzzalupo R, et al. (2009). Novel PEG-coated niosomes based on bola-surfactant as drug carries for 5-fluorouracil. Biomed Microdevices 10:9322-8.
8. El-Laithy HM, Shoukry O, Mahran LG. (2011). Novel sugar esters proniosomes for transdermal delivery of vinpocetine: preclinical and clinical studies. Eur J Pharm Biopharm 77:43-55.
9. Han QB, Zhou Y, Feng C, et al. (2009). Bioassay guided discovery of apoptosis inducers from gamboge by high-speed counter-current chromatography and high-pressure liquid chromatography/electrospray ionizationquadrupole time-of-flight mass spectrometry. J Chromatogr B 877:401-7.
10. Hao YM, Zhao F, Li N, et al. (2002). Studies on a high encapsulation of colchicines by a niosomes system. Int J Pharmaceutics 244:73-80.
11. Hong M, Zhu S, Jiang Y, et al. (2009). Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin. J Control Release 133:96-102.
12. Huang YZ, Chen J, Chen X, et al. (2008). PEGylated synthetic surfactant vesicles(Niosomes): novel carries for oligonucleotides. J Mater Sci: Mater Med 19:607-14.
13. Huang X, Chenb Y-J, Peng D-Y, et al. (2013). Solid liquid nanoparticles as delivery systems for Ganbogenic acid. Colloids Surf B: Biointerfaces 102:391-7.
14. Kopermsub P, Mayen V, Warin C. (2011). Potential use of niosomes for encapsulation of nisin and EDTA and their antibacterial activity enhancement. Food Res Int 44:605-12.
15. Kumar GP, Rajeshwarrao P. (2011). Nonionic surfactant vesicular systems for effective drug delivery-an overview. Acta Pharmaceutica Sin B 1:208-19.
16. Li QL, Cheng H, Zhu GQ. (2010). Gambogenic acid inhibits proliferation of A549 cells through apoptosis-inducing and cell cycle arresting. Biol Pharm Bull 33:415-20.
17. Manosroi A, Wongtrakul P, Manosroi J, et al. (2003). Characterization of vesicles prepared with various non-ionic surfactants mixed with cholesterol. Colloids Surf B: Biointerfaces 30:129-38.
18. Manosroi A, Jantrawut P, Manosroi J. (2008). Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharmaceutics 360:156-63.
19. Manosroi A, Khanrin P, Lohcharoenkal W, et al. (2010). Transdermal absorption enhancement through rat skin of gallidermin loaded in niosomes. Int J Pharmaceutics 392:304-10.
20. Marzio LD, Marianecci C, Petrone M, et al. (2011). Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20. Colloids Surf B: Biointerfaces 82:18-24.
21. Mehta SK, Jindal N, Kaur G. (2011). Quantitative investigation, stability and in vitro release studies of anti-TB drugs in Triton niosomes. Colloids Surf B: Biointerfaces 87:173-9.
22. Polino D, Coso D, Muzzzalupo R. (2008). Innovative bola-surfactant niosomes as topical delivery systems of 5-fluorouracil for the treatment of skin cancer. Int J Pharmaceutics 353:233-42.
23. Su W, Wang H, Wang S, et al. (2012). PEG/RGD-modified magnetic polymeric liposomes for controlled drug release and tumor cell targeting. Int J Pharmaceutics 426:170-81.
24. Uchegbu IF, Vyas SP. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharmaceutics 172:33-70.
25. Xie L, Li X-N, Jiang D-X, et al. (2011). Determination and pharmacokinetic study of catechin in rat plasma by HPLC. J Pharm Anal 1: 297-301.
26. Xu Z, Jin J, Siu LKS, et al. (2012). Folic acid conjugated mPEG-PEI600 as an efficient non-viral vector for targeted nucleic acid delivery. Int J Pharmaceutics 426:182-92.
27. Yan F, Wang M, Chen H, et al. (2012). Gambogenic acid mediated apoptosis through the mitochondrial oxidative stress and inactivation of Akt signaling pathway in human nasopharyngeal carcinoma CNE-1 cells. Eur J Pharmacol 33:181-90.